OOIR: Observatory of International Research

Papers

(The median citation count of Journal of Substance Abuse Treatment is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study	81
Substance use disorders among older populations: What role do race and ethnicity play in treatment and completion?	61
The impact of military sexual trauma and gender on receipt of evidence-based medication treatment among veterans with opioid use disorder	61
Uncommon and preventable: Perceptions of diversion of medication for opioid use disorder in jail	58
Life satisfaction among individuals with opioid use disorder receiving extended-release naltrexone: A 12-week randomized controlled trial and a 36-week follow-up	56
Examining differences in retention on medication for opioid use disorder: An analysis of Ohio Medicaid data	55
A qualitative study of service engagement and unmet needs among unstably housed people who inject drugs in Massachusetts	54
Sex-based differences in psychiatric symptoms and opioid abstinence during buprenorphine/naloxone treatment in adolescents with opioid use disorders	52
C2: editorial board	49
What is the relapse risk during treatment? Survivor analysis of single and multiple relapse events in inpatients with alcohol use disorder as part of an observational study	41
Al-Anon Intensive Referral (AIR): A qualitative formative evaluation for implementation	40
Education and careers were our way out	35
Serial mediation analysis of treatment-specific processes in two contrasting alcohol treatments	34
What is success in treatment for opioid use disorder? Perspectives of physicians and patients in primary care settings	33
Emergency department interventions for opioid use disorder: A synthesis of emerging models	32
Can nicotine replacement therapy be personalized? A statistical learning analysis	31
A randomized clinical trial evaluating the impact of counselor training and patient feedback on substance use disorder patients' sexual risk behavior	31
Incarceration and compulsory rehabilitation impede use of medication for opioid use disorder and HIV care engagement in Vietnam	31
Facing the future of substance use disorders treatment in Vietnam – A case study for international development and cooperation	28
Association between industry sponsorship and author conflicts of interest with outcomes of systematic reviews and meta-analyses of interventions for opioid use disorder	28
Connecting and disconnecting: Experiences of people with opioid use disorder in intensive outpatient treatment	27
Using machine learning to examine predictors of treatment goal change among individuals seeking treatment for alcohol use disorder	27
Adapting methadone inductions to the fentanyl era	27
Tobacco smoking and nicotine dependence among patients with respiratory diseases in Vietnam: Status and correlated factors	27
Suboptimal nonmedical qualities of primary care linked with care avoidance among people who use drugs in a Canadian setting amid an integrated health care reform	27

A randomized clinical trial of strengths-based case management to link emergency department patients to opioid use disorder treatment	26
Improving geographic access to methadone clinics	26
Frequency and recency of non-medical opioid use and death due to overdose or suicide among individuals assessed for risky substance use: A national registry study in Sweden	25
Drug court utilization of medications for opioid use disorder in high opioid mortality communities	25
The impact of COVID-19 on substance use disorder treatment in California: Service providers' perspectives	25
National trends in substance use treatment admissions for opioid use disorder among adults experiencing homelessness	25
Mobile-based brief interventions targeting cannabis-impaired driving among youth: A Delphi study	24
The impact of social network dynamics on engagement in drug use reduction programs among men and women who use drugs	24
Adapting and scaling a single site DEA X-waiver training program to a statewide initiative: Implementing GetWaiveredTX	24
Addressing adolescent substance use in an urban pediatric federally qualified health center	24
Development and validation of a claim-based provider-level measurement of use of medications to treat opioid use disorder	23
Engagement patterns with a digital therapeutic for substance use disorders: Correlations with abstinence outcomes	22
Latent class analysis of self-reported substance use during incarceration: Gender differences and associations with emotional distress and aggressiveness	22
Knowledge, attitudes, and behaviors related to the fentanyl-adulterated drug supply among people who use drugs in Oregon	22
Scoping review of interventions to link individuals to substance use services at discharge from jail	22
Beyond harm-producing versus harm-reducing: A qualitative meta-synthesis of people who use drugs' perspectives of and experiences with the extramedical use and diversion of buprenorphine	21
Recidivism prevention for impaired driving: Longitudinal 5-year outcomes from Quebec's severity-based intervention assignment program	21
The impact of COVID-19 on health care professionals who are exposed to drug-related deaths while supporting clients experiencing addiction	21
An exploration of thriving over time in recovery	21
Emotion dysregulation and hazardous drinking in relation to suicidal ideation among Spanish-speaking Latinx daily-smokers	20
C2: editorial board	20
Associations between prescription and illicit stimulant and opioid use in the United States, 2015–2020	20
Corrigendum to “Feasibility and acceptability of mindful recovery opioid use care continuum (M-ROCC): A concurrent mixed methods study” [Journal of Substance Abuse Treatment 130 (2021) 108415]	20
Contingency management for treatment attendance: A meta-analysis	19
Associations between patient experience and clinical outcomes in substance use disorder clinics: Findings from the veterans outcomes assessment survey	19
Racial disparities in linkage to care among patients with substance use disorders	19
Comparison of self-reported substance use with biological testing among treatment-seeking patients with opioid use disorder	19
Implementation of buprenorphine initiation and warm handoff protocols in emergency departments: A qualitative study of Pennsylvania hospitals	19
TOC (update)	18
Value of family involvement in substance use disorder treatment: Aligning clinical and financing priorities	18
C2: editorial board	18
Persons from racial and ethnic minority groups receiving medication for opioid use disorder experienced increased difficulty accessing harm reduction services during COVID-19	18
Follow-up after ED visits for opioid use disorder: Do they reduce future overdoses?	17
C2: editorial board	17
Developing a cascade of care for opioid use disorder among individuals in jail	17
Mobile low-threshold buprenorphine integrated with infectious disease services	17
Alcohol and drug use among bartenders: An at risk population?	17
Patient-centered primary care and receipt of evidence-based alcohol-related care in the national Veterans Health Administration	16
Consumer access to buprenorphine and methadone in certified community behavioral health centers: A secret shopper study	15
Associations between relationship quality and treatment-related stress among couples receiving methadone for opioid use disorder	15
Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder	15
The effect of nicotine dependence and withdrawal symptoms on use of nicotine replacement therapy: Secondary analysis of a randomized controlled trial in primary care	15
Prescribing buprenorphine for opioid use disorder in primary care: A survey of French general practitioners in the Sentinelles network	15
Client attitudes toward virtual treatment court	15
Introduction to a Special Issue: Care and treatment for substance use disorders: Studies from around the world	14
C2: editorial board	14
Qualitative characterizations of misinformed disclosure reactions to medications for opioid use disorders and their consequences	14
Treatment access for opioid use disorder in pregnancy among rural and American Indian communities	14
Opioid relapse and MOUD outcomes following civil commitment for opioid use	14
A systematic literature review of clinical trials and therapeutic applications of ibogaine	13

Treatment options and shared decision-making in the treatment of opioid use disorder: A scoping review	13
Association of facility characteristics and substance use disorder outcomes at discharge from residential treatment	13
Experiences of stigma in hospitals with addiction consultation services: A qualitative analysis of patients' and hospital-based providers' perspectives	13
A cohort study examining the relationship among housing status, patient characteristics, and retention among individuals enrolled in low-barrier-to-treatment-access methadone maintenance treatment	13
The role of recovery housing during outpatient substance use treatment	13
Accessibility of substance use treatment: A qualitative study from the non-service users' perspective	13
Behavioral activation for depression delivered by drug and alcohol treatment workers: A pilot randomized controlled trial	13
Corrigendum to “Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse” [Journal of Substance Abuse Treatment 131 (2021) 108447]	12
Psychosocial and behavioral therapy in conjunction with medication for opioid use disorder: Patterns, predictors, and association with buprenorphine treatment outcomes	12
TOC (update)	12
“In their mind, they always felt less than”: The role of peers in shifting stigma as a barrier to opioid use disorder treatment retention	12
Timing of smoking cessation treatment integrated into outpatient treatment with medications for opioid use disorder: Feasibility trial	12
TOC (update)	12
Changes in methadone take-home dosing before and after COVID-19	12
Diagnostic remission of substance use disorders: Racial differences and correlates of remission in a nationally representative sample	12
Cascade of care for office-based buprenorphine treatment in Bronx community clinics	11
The impact of race, gender, and heroin use on opioid addiction stigma	11
Traditions and Connections for Urban Native Americans (TACUNA): Utilizing community-based input to develop an opioid prevention intervention for urban American Indian/Alaska Native emerging adults	11
Maintenance on extended-release naltrexone is associated with reduced injection opioid use among justice-involved persons with opioid use disorder	11
Emergency department utilization by individuals with opioid use disorder who were recently incarcerated	11
Poking the bear: The inapplicability of the RNR principles for justice-involved women	11
From there to here: A journey through substance use disorder, prison, and recovery	11
Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic	11
Health care-seeking experiences for people who inject drugs with hepatitis C: Qualitative explorations of stigma	11
Association between availability of medications for opioid use disorder in specialty treatment and use of medications among patients: A state-level trends analysis	11
Motivational interviewing telephone counseling to increase postpartum maintenance of abstinence from tobacco	11
TOC (update)	10
The Emergency Department Longitudinal Integrated Care (ED-LINC) intervention targeting opioid use disorder: A pilot randomized clinical trial	10
TOC (update)	10
Gender differences in patient outcomes following drug abuse treatment in Afghanistan: Results from a new evaluation	10
Characterizing nicotine withdrawal in smokers experiencing homelessness	10
SBIRT administered by mental health counselors for hospitalized adults with substance misuse or disordered use: Evaluating hospital utilization and costs	10
Modeling the cost and impact of injectable opioid agonist therapy on overdose and overdose deaths	9
A pilot randomized trial of CBT4CBT for women in residential treatment for substance use disorders	9
Beyond state scope of practice laws for advanced practitioners: Additional supervision requirements for buprenorphine prescribing	9
Effects of Medicaid Health Homes among people with substance use disorder and another chronic condition on health care utilization and spending: Lessons from New York State	9
Integration of pharmacotherapy for alcohol use disorder treatment in primary care settings: A scoping review	9
Factors associated with clinician treatment recommendations for patients with a new diagnosis of opioid use disorder	9
A randomized pilot trial of a mobile phone–based brief intervention with personalized feedback and interactive text messaging to reduce driving after cannabis use and riding with a cannabis impaired d	9
A scoping review of alcohol, tobacco, and other drug use treatment interventions for sexual and gender minority populations	9
Did drug use increase following COVID-19 relaxation of methadone take-out regulations? 2020 was a complicated year	9
Successful transfer of stable patients on opioid agonist therapies from specialty addiction treatment to primary care settings in Ukraine: A pilot study	9
“If I had them, I would use them every time”: Perspectives on fentanyl test strip use from people who use drugs	9
Trends and age-related disparities in opioid use disorder treatment admissions for adolescents and young adults	9
National trends in buprenorphine prescribing before and during the COVID-19 pandemic	9
Community coalition and key stakeholder perceptions of the community opioid epidemic before an intensive community-level intervention	8
Comparing telemedicine to in-person buprenorphine treatment in U.S. veterans with opioid use disorder	8
TOC (update)	8
Ethnic discrimination and alcohol-related problem severity among Hispanic/Latin drinkers: The role of social anxiety in the minority stress model	8
TOC (update)	8
Tobacco use among substance use disorder (SUD) treatment staff is associated with tobacco-related services received by clients	8
HealthCall: A randomized trial assessing a smartphone enhancement of brief interventions to reduce heavy drinking in HIV care	8
The phenotype of recovery VIII: Association among delay discounting, recovery capital, and length of abstinence among individuals in recovery from substance use disorders	8
Finding a fair deal: Policies on alcohol and drugs at “wet” eldercare facilities	8
Homelessness and publicly funded substance use disorder treatment in California, 2016–2019: Analysis of treatment needs, level of care placement, and outcomes	8
Effects of contingency management and use of reminders for drug use treatment on readmission and criminality among young people: A linkage study of a randomized trial	8
Risk behaviors among persons civilly committed for opioid use	7
Retention in care for persons with opioid use disorder transitioning from sublingual to injectable buprenorphine	7
Multimorbidity classes indicate differential patterns of health care engagement among people who inject drugs	7
Kindness, connection, and science	7
Deaths associated with opioids, race and ethnicity, and years of potential life lost in Washington State	7
TOC (update)	7
Evaluating disparities in prescribing of naloxone after emergency department treatment of opioid overdose	7
Reducing tobacco use in substance use treatment: An intervention to promote tobacco-free grounds	7
Predicting longitudinal service use for individuals with substance use disorders: A latent profile analysis	7
Correlates of methamphetamine use severity among patients receiving methadone maintenance treatment for opioid use disorder in Vietnam	7
Teaching residents to prescribe buprenorphine for opioid use disorder: Insights from a community-based residency program	7
Predictors of therapeutic alliance, treatment feedback, and clinical outcomes among African American women in treatment for co-occurring PTSD and SUD	7
Predicting drug court graduation: Examining the role of individual and programmatic characteristics	7
C2: editorial board	7
Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program	7
Utility of interactive voice response self-monitoring in stabilizing initial change during natural recovery attempts among persons with alcohol use disorder	7
Predictors of engagement and retention in care at a low-threshold substance use disorder bridge clinic	7
Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis	7